Table 2 Characteristics of active SLE patients with renal and non-renal involvement
| Â | Renal active ( n = 19) | Non-renal active ( n = 18) |
|---|---|---|
No. male/female | 5/14 | 2/16 |
Age (yrs), median (range) | 38 (18 to 73) | 37 (19.60) |
SLEDAI, median (range) | 12 (6 to 16) *** | 8 (5 to 10) |
Anti-dsDNA (E/ml), median (range) | 230 (7 to 6,683) | 234 (3 to 1,000) |
C3 (g/l), median (range) | 0.58 (0.21 to 1.12) * | 0.91 (0.37 to 1.68) |
C4 (g/l), median (range) | 0.10 (0.04 to 0.30) | 0.13 (0.02 to 0.27) |
CRP (g/l), median (range) | 5 (1 to 81) | 9.5 (3 to 92) |
No. with/without treatment | 17/2 | 12/6 |
Users of Prednisone (%) Dose (mg/day), median (range) | 14 (78%) 6.25 (2.5 to 100) | 7 (39%) 7.50 (5 to 20) |
Users of Azathioprine (%) Dose (mg/day), median (range) | 2 (11%) 87.5 (75 to 100) | 3 (17%) 125 (100 to 150) |
Users of Hydroxychloroquine (%) Dose (mg/day), median (range) | 8 (42%) 400 (200 to 400) | 8 (44%) 400 (200 to 1,200) |